You just read:

Abuse, Addiction, and Opioid Poisoning Results In Commercially-Insured Individuals Following Introduction of Reformulated OxyContin® (oxycodone HCl extended-release tablets) CII

News provided by

Purdue Pharma L.P.

Mar 23, 2015, 09:00 ET